Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Luye Pharma Announces U.S. FDA Approval of ERZOFRI® (paliperidone palmitate) Extended-Release Injectable Suspension for Treating Schizophrenia and Schizoaffective Disorder 2024-07-28 21:48
Pierre Fabre Laboratories receives CHMP positive opinion for BRAFTOVI® (encorafenib) in combination with MEKTOVI® (binimetinib) for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC) with a BRAFV600E mutation 2024-07-26 23:21
MHX Jakarta 18-21 July 2024 Wrapped Up with Record Turnout, High Leads Generation and Strategic Partnerships 2024-07-26 21:02
ReviR Therapeutics Raises $30 Million Series A Financing to Advance its Proprietary Oral Genetic Medicines for Multiple CNS Disorders 2024-07-26 21:00
CStone Announces European Commission Approval of Sugemalimab (Cejemly®) as First-Line Treatment for Non-Small Cell Lung Cancer 2024-07-26 20:16
MGI and HKBU Collaborate on Advanced Sequencing Technology to Combat Doping in Sports 2024-07-26 19:35
HanAll Biopharma Reports Q2 2024 Financial Results and Provides Business Update 2024-07-26 19:00
Sanyou Bio Congratulates Eluminex Biosciences and Foreseen Biotechnology on Major Breakthroughs in Innovative Drug Project 2024-07-26 18:00
Vantage Australia Explores HealthTech's Future in the Latest Episode of The Vantage View 2024-07-26 17:05
Vantage Markets Reveals "The Future of HealthTech" in the Latest Episode of The Vantage View 2024-07-26 17:05
Harbour BioMed to Present the Latest Progress of the First-in-Class Fully Human Anti-B7H7/HHLA2 Monoclonal Antibody HBM1020 at the ESMO Congress 2024 2024-07-26 10:16
Innovent and WeComput Announce Strategic Partnership to Advance AI-Driven Drug Discovery and Development 2024-07-26 09:33
2024 Milken Institute Asia Summit Casts Spotlight on Impactful Ideas and Purposeful Action 2024-07-26 09:02
Angel Yeast Showcases Innovative Yeast Protein Solutions at Growth Asia 2024 2024-07-26 01:20
Neurophet to launch total solution for AD treatments 'Neurophet AQUA AD' at AAIC 2024 2024-07-25 21:00
Peijia Medical's Licensing Partner, JenaValve Technology, Inc., is Expected to be Acquired by Edwards Lifesciences 2024-07-25 20:30
Ractigen Announces U.S. FDA Rare Pediatric Disease Designation (RPDD) Granted to RAG-18 for the treatment of Duchenne Muscular Dystrophy 2024-07-25 20:00
IASO Bio Announces NMPA Approval of IND Application for IASO-782 for Treatment of New Indication -- Systemic Lupus Erythematosus (SLE) 2024-07-25 17:46
ObvioHealth announces strategic investment by Guardant Health to accelerate deployment of oncology clinical trials globally 2024-07-25 16:39
MoU signing between HCSA Community Services and Tzu-Chi Foundation (Singapore) to support Hepatitis C elimination initiative for former drug abusers in Singapore 2024-07-25 11:30
1 56 57 58 59 60 1596